- Home
- OKYO vs LGL Comparison
OKYO vs LGL Comparison
Compare OKYO & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- LGL
- Stock Information
- Founded
- OKYO 2007
- LGL 1917
- Country
- OKYO United Kingdom
- LGL United States
- Employees
- OKYO N/A
- LGL N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- LGL Industrial Machinery/Components
- Sector
- OKYO Health Care
- LGL Technology
- Exchange
- OKYO Nasdaq
- LGL Nasdaq
- Market Cap
- OKYO 37.0M
- LGL 39.1M
- IPO Year
- OKYO 2022
- LGL N/A
- Fundamental
- Price
- OKYO $1.19
- LGL $6.32
- Analyst Decision
- OKYO Strong Buy
- LGL
- Analyst Count
- OKYO 1
- LGL 0
- Target Price
- OKYO $7.00
- LGL N/A
- AVG Volume (30 Days)
- OKYO 143.7K
- LGL 5.3K
- Earning Date
- OKYO 04-08-2025
- LGL 05-14-2025
- Dividend Yield
- OKYO N/A
- LGL N/A
- EPS Growth
- OKYO N/A
- LGL 66.76
- EPS
- OKYO N/A
- LGL 0.08
- Revenue
- OKYO N/A
- LGL $4,292,000.00
- Revenue This Year
- OKYO N/A
- LGL N/A
- Revenue Next Year
- OKYO N/A
- LGL N/A
- P/E Ratio
- OKYO N/A
- LGL $81.63
- Revenue Growth
- OKYO N/A
- LGL 26.49
- 52 Week Low
- OKYO $0.81
- LGL $4.86
- 52 Week High
- OKYO $1.74
- LGL $7.28
- Technical
- Relative Strength Index (RSI)
- OKYO 45.06
- LGL 46.82
- Support Level
- OKYO $1.31
- LGL $6.17
- Resistance Level
- OKYO $1.48
- LGL $7.28
- Average True Range (ATR)
- OKYO 0.11
- LGL 0.47
- MACD
- OKYO -0.03
- LGL 0.00
- Stochastic Oscillator
- OKYO 17.07
- LGL 38.13
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.